Andrographolide suppresses RANKL‐induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo
Open Access
- 11 October 2013
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 171 (3) , 663-675
Abstract
Background and Purpose: Osteoclasts play a pivotal role in diseases such as osteoporosis, rheumatoid arthritis and tumour bone metastasis. Thus, searching for natural compounds that may suppress osteoclast formation and/or function is promising for the treatment of osteoclast‐related diseases. Here, we examined changes in osteoclastogenesis and LPS‐induced osteolysis in response to andrographolide (AP), a diterpenoid lactone isolated from the traditional Chinese and Indian medicinal plant Andrographis paniculata.Experimental Approach: Effects of AP on osteoclast differentiation and bone resorption were measured in vitro. Western blots and RT‐PCR techniques were used to examine the underlying molecular mechanisms. The bone protective activity of AP in vivo was assessed in a mouse model of osteolysis.Key Results: AP concentration‐dependently suppressed RANKL‐mediated osteoclast differentiation and bone resorption in vitro and reduced the expression of osteoclast‐specific markers, including tartrate‐resistant acid phosphatase, calcitonin receptors and cathepsin K. Further molecular analysis revealed that AP impaired RANKL‐induced NF‐κB signalling by inhibiting the phosphorylation of TGF‐β‐activated kinase 1, suppressing the phosphorylation and degradation of IκBα, and subsequently preventing the nuclear translocation of the NF‐κB p65 subunit. AP also inhibited the ERK/MAPK signalling pathway without affecting p38 or JNK signalling.Conclusions and Implications: AP suppressed RANKL‐induced osteoclastogenesis through attenuating NF‐κB and ERK/MAPK signalling pathways in vitro, thus preventing bone loss in vivo. These data indicated that AP is a promising natural compound for the treatment of osteoclast‐related bone diseases.Keywords
Funding Information
- Program for Innovative Research Team of Shanghai Municipal Education Commission
- Shanghai Municipal Education Commission (13YZ031)
- Key Disciplines of Shanghai Municipal Education Commission of China (J50206)
- National Natural Science Foundation for the Youth of China (81201364)
- State Human Resource Ministry
This publication has 65 references indexed in Scilit:
- V-ATPases in osteoclasts: Structure, function and potential inhibitors of bone resorptionThe International Journal of Biochemistry & Cell Biology, 2012
- Versatile Roles of V-ATPases Accessory Subunit Ac45 in Osteoclast Formation and FunctionPLOS ONE, 2011
- Bone resorption in syndromes of the Ras/MAPK pathwayClinical Genetics, 2010
- Role of NF-κB in the skeletonCell Research, 2010
- Guidelines for reporting experiments involving animals: the ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- A TNF receptor loop peptide mimic blocks RANK ligand–induced signaling, bone resorption, and bone lossJournal of Clinical Investigation, 2006
- Osteoclast differentiation and activationNature, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Tumor necrosis factor‐α mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism†Journal of Cellular Biochemistry, 2001